L
Lexeo Therapeutics
New York, United States
Founded 2017 NASDAQ: LXEO
Nanomedicine Gene Therapy Delivery Nano-Bio Cell Therapy Nano Protein Nanoparticles Lipid Nanoparticles
About
Gene therapy company developing treatments for cardiac and neurological diseases
Company Details
- Type
- public
- Employees
- 100+
- Funding
- Public
Key Products
- LX2006
- LX2020
- LX1004